DK1425005T3 - Farmaceutisk sammensætning indeholdende lumiracoxib - Google Patents

Farmaceutisk sammensætning indeholdende lumiracoxib

Info

Publication number
DK1425005T3
DK1425005T3 DK02767455T DK02767455T DK1425005T3 DK 1425005 T3 DK1425005 T3 DK 1425005T3 DK 02767455 T DK02767455 T DK 02767455T DK 02767455 T DK02767455 T DK 02767455T DK 1425005 T3 DK1425005 T3 DK 1425005T3
Authority
DK
Denmark
Prior art keywords
lumiracoxib
pharmaceutical composition
composition containing
pharmaceutical
containing lumiracoxib
Prior art date
Application number
DK02767455T
Other languages
Danish (da)
English (en)
Inventor
Anees Abdulquadar Karnachi
Simon David Bateman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1425005T3 publication Critical patent/DK1425005T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02767455T 2001-08-31 2002-08-30 Farmaceutisk sammensætning indeholdende lumiracoxib DK1425005T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31638901P 2001-08-31 2001-08-31

Publications (1)

Publication Number Publication Date
DK1425005T3 true DK1425005T3 (da) 2006-09-04

Family

ID=23228840

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02767455T DK1425005T3 (da) 2001-08-31 2002-08-30 Farmaceutisk sammensætning indeholdende lumiracoxib

Country Status (30)

Country Link
US (2) US20030114527A1 (fr)
EP (1) EP1425005B1 (fr)
JP (1) JP4636796B2 (fr)
KR (1) KR100895551B1 (fr)
CN (1) CN100406008C (fr)
AR (1) AR036312A1 (fr)
AT (1) ATE324883T1 (fr)
AU (1) AU2002331094B2 (fr)
BR (1) BR0212155A (fr)
CA (1) CA2456604C (fr)
CO (1) CO5560554A2 (fr)
CY (1) CY1106137T1 (fr)
DE (1) DE60211183T2 (fr)
DK (1) DK1425005T3 (fr)
EC (1) ECSP044986A (fr)
ES (1) ES2263813T3 (fr)
HK (1) HK1087336A1 (fr)
HU (1) HUP0401429A2 (fr)
IL (1) IL160375A0 (fr)
MX (1) MXPA04001933A (fr)
MY (1) MY137516A (fr)
NO (1) NO20040860L (fr)
NZ (1) NZ531342A (fr)
PE (1) PE20030323A1 (fr)
PL (1) PL367464A1 (fr)
PT (1) PT1425005E (fr)
RU (1) RU2329801C2 (fr)
SI (1) SI1425005T1 (fr)
WO (1) WO2003020261A1 (fr)
ZA (1) ZA200400877B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020351A1 (es) * 2000-09-11 2002-06-14 Novartis Ag Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
GB0201520D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Pharmaceutical uses
CN1330300C (zh) * 2002-03-07 2007-08-08 诺瓦提斯公司 药物组合物
US8148414B2 (en) 2008-08-19 2012-04-03 Xenoport, Inc. Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
US20140093563A1 (en) * 2011-06-13 2014-04-03 Ranbaxy Laboratories Limited Febuxostat compositions
US10952968B2 (en) 2012-05-14 2021-03-23 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
EP2887934A1 (fr) 2012-08-22 2015-07-01 XenoPort, Inc. Méthodes d'administration du monométhyl fumarate et des promédicaments associés présentant des effets secondaires réduits
WO2014031897A1 (fr) 2012-08-22 2014-02-27 Xenoport, Inc. Formes pharmaceutiques orales possédant une charge élevée de (n,n-diéthylcarbamoyl)méthyl méthyl(2e)but-2-ène-l,4-dioate
EA018867B1 (ru) * 2012-11-01 2013-11-29 Лаборатория Тютор С.А.С.И.Ф.И.А. Способ получения фармацевтической композиции и продукт способа
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (fr) 2013-06-07 2014-12-11 Xenoport, Inc. Procédé de production de monométhylfumarate
WO2014205392A1 (fr) 2013-06-21 2014-12-24 Xenoport, Inc. Co-cristaux de diméthyl fumarate
EP3041467A1 (fr) 2013-09-06 2016-07-13 XenoPort, Inc. Formes cristallines de méthyl(2e)but-2-ène-1,4-dioate de (n,n-diéthylcarbamoyl)méthyle, procédés de synthèse et d'utilisation
WO2015105992A1 (fr) * 2014-01-10 2015-07-16 Mcneil-Ppc, Inc. Procédé pour fabriquer un comprimé par radiofréquence et particules revêtues à perte
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
EP3162362A1 (fr) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Comprimé optimisé a une haute dose contenant de la mesalazine
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0701449B1 (fr) * 1993-06-08 2003-08-06 Novartis AG Procede de preparation d'une forme galenique orale solide contenant du diclofenac
KR100373622B1 (ko) * 1996-05-17 2003-07-12 머크 앤드 캄파니 인코포레이티드 사이클로옥시게나제-2로매개된질환의1일1회치료용조성물
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
PE20020351A1 (es) * 2000-09-11 2002-06-14 Novartis Ag Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2

Also Published As

Publication number Publication date
WO2003020261A1 (fr) 2003-03-13
NO20040860L (no) 2004-04-22
CA2456604C (fr) 2011-02-08
KR100895551B1 (ko) 2009-04-29
MY137516A (en) 2009-02-27
ECSP044986A (es) 2004-04-28
PE20030323A1 (es) 2003-05-12
CN100406008C (zh) 2008-07-30
PT1425005E (pt) 2006-09-29
HK1087336A1 (en) 2006-10-13
DE60211183T2 (de) 2007-02-01
ATE324883T1 (de) 2006-06-15
RU2329801C2 (ru) 2008-07-27
HUP0401429A2 (hu) 2004-11-29
AR036312A1 (es) 2004-08-25
US20030114527A1 (en) 2003-06-19
US20070231382A1 (en) 2007-10-04
AU2002331094B2 (en) 2006-08-31
EP1425005B1 (fr) 2006-05-03
JP4636796B2 (ja) 2011-02-23
EP1425005A1 (fr) 2004-06-09
CY1106137T1 (el) 2011-06-08
NZ531342A (en) 2005-09-30
ZA200400877B (en) 2004-11-01
SI1425005T1 (sl) 2006-12-31
BR0212155A (pt) 2004-07-13
ES2263813T3 (es) 2006-12-16
RU2004109920A (ru) 2005-04-20
CN1728993A (zh) 2006-02-01
PL367464A1 (en) 2005-02-21
DE60211183D1 (de) 2006-06-08
CO5560554A2 (es) 2005-09-30
JP2005520785A (ja) 2005-07-14
IL160375A0 (en) 2004-07-25
CA2456604A1 (fr) 2003-03-13
KR20040031019A (ko) 2004-04-09
MXPA04001933A (es) 2004-06-15

Similar Documents

Publication Publication Date Title
FI20011478A (fi) Farmaseuttinen koostumus
DK1524266T3 (da) Farmaceutisk sammensætning
EP1450824A4 (fr) Composition pharmaceutique
FR2824267B1 (fr) Composition cosmetique filmogene
EE200300416A (et) Ravimvorm
DK1395242T3 (da) Flydende farmaceutisk sammensætning
EE05020B1 (et) Glburiidi ravimkoostis
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
EE200300589A (et) Ravimkoostised
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib
EP1408896A4 (fr) Composition pharmaceutique
FI20022128A0 (fi) Farmaseuttinen koostumus
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
FR2819176B1 (fr) Composition cosmetique pelable
PL370037A1 (en) Pharmaceutical composition
FR2830751B1 (fr) Composition cosmetique filmogene
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger
IL157411A0 (en) Pharmaceutical composition
SE0100847D0 (sv) Novel pharmaceutical composition